Not logged in Share Save
The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine Hashimoto, Tadayoshi; Nakamura, Yoshiaki; Fujisawa, Takao; Imai, Mitsuho; Shibuki, Taro; Iida, Naoko; Ozaki, Hiroshi; Nonomura, Norio; Morizane, Chigusa; Iwata, Hiroji; Okano, Susumu; Yamagami, Wataru; Yamazaki, Naoya; Kadowaki, Shigenori; Taniguchi, Hiroya; Ueno, Makoto; Boku, Shogen; Oki, Eiji; Komatsu, Yoshito; Yuki, Satoshi; Makiyama, Akitaka; Otsuka, Tomoyuki; Hara, Hiroki; Okano, Naohiro; Nishina, Tomohiro; Sakamoto, Yasutoshi; Miki, Izumi; Kobayashi, Shin; Yuda, Junichiro; Kageyama, Shun-Ichiro; Nagamine, Michiko; Sakashita, Shingo; Sakamoto, Naoya; Yamashita, Riu; Koga, Yoshikatsu; Bando, Hideaki; Ishii, Genichiro; Kuwata, Takeshi; Park, Woong-Yang; Ohtsu, Atsushi; Yoshino, Takayuki Share Save
Appropriate Relevancy and Reliability of Real-World Data for the Utilization of Regulatory Submission Bando, Hideaki; Misumi, Toshihiro; Sakamoto, Yasutoshi; Takeda, Yuriko; Nakamura, Yoshiaki; Mizuguchi, Kazuya; Aoyagi, Yoshihiro; Miki, Izumi; Kuroda, Tomohiro; Kasai, Ryu; Suzuki, Takuya; Yoshino, Takayuki; Ohtsu, Atsushi Share Save
Share Save
Trajectory for the Regulatory Approval of a Combination of Pertuzumab Plus Trastuzumab for Pre-treated HER2-positive Metastatic Colorectal Cancer Using Real-world Data Sakamoto, Yasutoshi; Bando, Hideaki; Nakamura, Yoshiaki; Hasegawa, Hiromi; Kuwaki, Takako; Okamoto, Wataru; Taniguchi, Hiroya; Aoyagi, Yoshihiro; Miki, Izumi; Uchigata, Hiroshi; Kuramoto, Naomi; Fuse, Nozomu; Yoshino, Takayuki; Ohtsu, Atsushi Share Save
Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer Van Cutsem, E.; Hochster, H.; Shitara, K.; Mayer, R.; Ohtsu, A.; Falcone, A.; Yoshino, T.; Doi, T.; Ilson, D. H.; Arkenau, H-T; George, B.; Benhadji, K. A.; Makris, L.; Tabernero, J. Share Save
Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial Tabernero, Josep; Hoff, Paulo M.; Shen, Lin; Ohtsu, Atsushi; Shah, Manish A.; Siddiqui, Asna; Heeson, Sarah; Kiermaier, Astrid; Macharia, Harrison; Restuccia, Eleonora; Kang, Yoon-Koo Share Save
Share Save
Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis Yoshino, T.; Van Cutsem, E.; Li, J.; Shen, L.; Kim, T. W.; Sriuranpong, V; Xuereb, L.; Aubel, P.; Fougeray, R.; Cattan, V; Amellal, N.; Ohtsu, A.; Mayer, R. J. Share Save
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer Yoshino, T.; Argiles, G.; Oki, E.; Martinelli, E.; Taniguchi, H.; Arnold, D.; Mishima; Li, Y.; Smruti, B. K.; Ahn, J. B.; Faud, I.; Chee, C. E.; Yeh, K. -h.; Lin, P. -c.; Chua, C.; Hasbullah, H. H.; Lee, M. A.; Sharma, A.; Sun, Y.; Curigliano, G.; Bando, H.; Lordick, F.; Yamanaka, T.; Tabernero, J.; Baba, E.; Cervantes, A.; Ohtsu, A.; Peters, S.; Ishioka, C.; Pentheroudakis, G. Share Save
Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial Nakamura, Yoshiaki; Okamoto, Wataru; Kato, Takeshi; Esaki, Taito; Kato, Ken; Komatsu, Yoshito; Yuki, Satoshi; Masuishi, Toshiki; Nishina, Tomohiro; Ebi, Hiromichi; Sawada, Kentaro; Taniguchi, Hiroya; Fuse, Nozomu; Nomura, Shogo; Fukui, Makoto; Matsuda, Seiko; Sakamoto, Yasutoshi; Uchigata, Hiroshi; Kitajima, Kana; Kuramoto, Naomi; Asakawa, Takashi; Olsen, Steve; Odegaard, Justin, I; Sato, Akihiro; Fujii, Satoshi; Ohtsu, Atsushi; Yoshino, Takayuki Share Save
Large-scale prospective genome-wide association study of oxaliplatin in stage II/III colon cancer and neuropathy Kanai, M.; Kawaguchi, T.; Kotaka, M.; Manaka, D.; Hasegawa, J.; Takagane, A.; Munemoto, Y.; Kato, T.; Eto, T.; Touyama, T.; Matsui, T.; Shinozaki, K.; Matsumoto, S.; Mizushima, T.; Mori, M.; Sakamoto, J.; Ohtsu, A.; Yoshino, T.; Saji, S.; Matsuda, F. Share Save
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial Fuchs, Charles S.; Ozguroglu, Mustafa; Bang, Yung-Jue; Di Bartolomeo, Maria; Mandala, Mario; Ryu, Min-Hee; Fornaro, Lorenzo; Olesinski, Tomasz; Caglevic, Christian; Chung, Hyun C.; Muro, Kei; Van Cutsem, Eric; Elme, Anneli; Thuss-Patience, Peter; Chau, Ian; Ohtsu, Atsushi; Bhagia, Pooja; Wang, Anran; Shih, Chie-Schin; Shitara, Kohei Share Save
Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial Yamazaki, K.; Yamanaka, T.; Shiozawa, M.; Manaka, D.; Kotaka, M.; Gamoh, M.; Shiomi, A.; Makiyama, A.; Munemoto, Y.; Rikiyama, T.; Fukunaga, M.; Ueki, T.; Shitara, K.; Shinkai, H.; Tanida, N.; Oki, E.; Sunami, E.; Ohtsu, A.; Maehara, Y.; Yoshino, T. Share Save
Impact of dihydropyrimidine dehydrogenase (DPD) genotype on fluoropyrimidine-related toxicity in Asian population Kanai, M.; Kawaguchi, T.; Kotaka, M.; Manaka, D.; Hasegawa, J.; Takagane, A.; Munemoto, Y.; Kato, T.; Eto, T.; Touyama, T.; Matsui, T.; Shinozaki, K.; Mizushima, T.; Matsumoto, S.; Mori, M.; Ohtsu, A.; Saji, S.; Yoshino, T.; Matsuda, F. Share Save
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies Nakamura, Yoshiaki; Taniguchi, Hiroya; Ikeda, Masafumi; Bando, Hideaki; Kato, Ken; Morizane, Chigusa; Esaki, Taito; Komatsu, Yoshito; Kawamoto, Yasuyuki; Takahashi, Naoki; Ueno, Makoto; Kagawa, Yoshinori; Nishina, Tomohiro; Kato, Takeshi; Yamamoto, Yoshiyuki; Furuse, Junji; Denda, Tadamichi; Kawakami, Hisato; Oki, Eiji; Nakajima, Takako; Nishida, Naohiro; Yamaguchi, Kensei; Yasui, Hisateru; Goto, Masahiro; Matsuhashi, Nobuhisa; Ohtsubo, Koushiro; Yamazaki, Kentaro; Tsuji, Akihito; Okamoto, Wataru; Tsuchihara, Katsuya; Yamanaka, Takeharu; Miki, Izumi; Sakamoto, Yasutoshi; Ichiki, Hiroko; Hata, Masayuki; Yamashita, Riu; Ohtsu, Atsushi; Odegaard, Justin, I; Yoshino, Takayuki Share Save
OS and long-term DFS with 3-vs. 6-month adjuvant oxaliplatin and fluoropyrimidine-based therapy for stage III colon cancer patients: A randomized phase III ACHIEVE trial Yoshino, T.; Kotaka, M.; Manaka, D.; Eto, T.; Hasegawa, J.; Takagane, A.; Nakamura, M.; Kato, T.; Munemoto, Y.; Nakamura, F.; Bando, H.; Taniguchi, H.; Sakamoto, Y.; Shiozawa, M.; Nishi, M.; Horiuchi, T.; Mizushima, T.; Yamanaka, T.; Ohtsu, A.; Mori, M. Share Save
End-of-study analysis from JACOB: A phase III study of pertuzumab (P) plus trastuzumab (H) and chemotherapy (CT) in HER2-positive metastatic gastric or gastro-esophageal junction cancer (mGC/GEJC) Tabernero, J.; Hoff, P. M.; Shen, L.; Ohtsu, A.; Shah, M. A.; Siddiqui, A.; Heeson, S.; Wu, H.; Restuccia, E.; Kang, Y-K. Share Save
Prognostic effect of postoperative serum carcinoembryonic antigen (CEA) combined with T4 versus T3 tumors in patients with high-risk stage 2 colon cancer: ACHIEVE-2 phase III randomized clinical trial Shiomi, A.; Shiozawa, M.; Manaka, D.; Kotaka, M.; Sakamoto, Y.; Makiyama, A.; Munemoto, Y.; Rikiyama, T.; Fukunaga, M.; Ueki, T.; Shitara, K.; Shinkai, H.; Tanida, N.; Oki, E.; Yamanaka, T.; Sunami, E.; Yamazaki, K.; Ohtsu, A.; Maehara, Y.; Yoshino, T. Share Save
KEYNOTE-061: Response to subsequent therapy following second-line pembrolizumab or paclitaxel in patients with advanced gastric or gastroesophageal junction adenocarcinoma Yoon, H.; Fuchs, C.; Ozguroglu, M.; Bang, Y.; Di Bartolomeo, M.; Mandala, M.; Ryu, M.; Fornaro, L.; Olesinski, T.; Caglevic, C.; Chung, H.; Muro, K.; Van Cutsem, E.; Elme, A.; Thuss-Patience, P.; Chau, I.; Ohtsu, A.; Wang, A.; Bhagia, P.; Lin, J.; Shih, C.; Shitara, K. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
